Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.95)
# 3,008
Out of 4,876 analysts
38
Total ratings
50%
Success rate
0.82%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $4.46
Upside: +101.79%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $36.58
Upside: -17.99%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $72.35
Upside: -11.54%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $16.79
Upside: +1.25%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $57.03
Upside: +10.47%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $73.37
Upside: +47.20%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $62.88
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $171.36
Upside: -19.47%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $105.62
Upside: +33.50%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $46.38
Upside: +35.83%
Initiates: Underperform
Price Target: $42
Current: $42.88
Upside: -2.05%
Initiates: Outperform
Price Target: $41
Current: $32.28
Upside: +27.01%
Initiates: Outperform
Price Target: $29
Current: $31.93
Upside: -9.18%
Initiates: Underperform
Price Target: $74
Current: $62.87
Upside: +17.70%
Initiates: Outperform
Price Target: n/a
Current: $15.76
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.51
Upside: +27.83%
Initiates: Outperform
Price Target: $66
Current: $102.30
Upside: -35.48%
Initiates: Outperform
Price Target: $38
Current: $16.87
Upside: +125.25%
Initiates: Outperform
Price Target: $886
Current: $785.11
Upside: +12.85%
Downgrades: Hold
Price Target: $31$30
Current: $27.10
Upside: +10.70%
Initiates: Buy
Price Target: $21
Current: $11.78
Upside: +78.27%
Downgrades: Hold
Price Target: $21$25
Current: $10.26
Upside: +143.66%
Upgrades: Buy
Price Target: n/a
Current: $30.17
Upside: -